Therapeutic targets that impact both cardiac and cerebral functions in CNS neurological disorders

Recent advancements highlight the intricate interplay between the heart and brain, underscoring their profound influence on each other, especially concerning central nervous system (CNS) neurological disorders.

Faster Drug Discovery: Yseop & AWS Unveils GenAI Tool for Biopharma R&D

What You Should Know: · Yseop, a world-leading Artificial Intelligence (AI) software company and pioneer in Generative AI, has announced today the development of an

May 3, 2024

Illumina board agrees to spin off Grail rather than sell the cancer diagnostics firm

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 4, 2024

Lilly extends tender offer for $2.4bn Dice acquisition

ELi Lilly and Dice entered a definitive agreement on 20 June 2023 for the proposed takeover. Credit: Jonathan Weiss / Shutterstock.com. Eli Lilly has extended

July 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.